Interesting that studies with humans have been going on since as far back as 2008 with the MBI technology, more than 8 years ago. With mhtx yet to receive approval to even begin human trials, and only about $2 million in cash, what do you think lies ahead on the dilution front for current shareholders?
News 
Market Data 
Discover 
